India, US to increase cooperation in pharma trade: Sharma

The Commissioner, U.S. Food and Drug Administration (USFDA), Margaret A. Hamburg meeting the Union Minister for Commerce & Industry, Anand Sharma, in New Delhi on Feb 10.

Top Stories

»	Budget 2026 to focus on defence, capex, infrastructure, fiscal discipline
»	Economic Survey projects India’s GDP growth at 6.8 to 7.2 per cent for FY27
»	Sensex up over 500 points, Nifty crosses 25,350 buoyed by India-EU FTA
»	Sensex, Nifty end higher as India-EU trade deal boosts sentiment
»	EU trade deal biggest in India's history, to create huge opportunities: PM Modi

SME Times News Bureau | 11 Feb, 2014
India and the US are in talks to create an "institutional mechanism" to address issues related to trade and investments in healthcare and pharmaceuticals sector, Commerce and Industry Minister Anand Sharma said Monday.

"We have discussed the pharmaceutical issues very clearly. And also about the cooperation in this sector," said Sharma, adding the visiting US official also offered her cooperation in this regard.

Talking to reporters after meeting Commissioner for US Food and Drug Administration (FDA) Margaret Hamburg in New Delhi, Sharma said both sides recognise importance of the partnership and are willing to address the issue affecting it.

"When we talk of creating an institutional mechanism, to address any issue which may come up, which has been agreed to, I think we are satisfied. Because that’s how matters get addressed," he said.

"These issues do come up before the countries also, within our own industry, or the US may have their own industry. What is important is the willingness to address those issues, and resolve matters, which we have definitely mentioned," he added.